SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bejar Rafael – ‘4’ for 1/1/20 re: Aptose Biosciences Inc.

On:  Friday, 1/3/20, at 4:00pm ET   ·   For:  1/1/20   ·   Accession #:  1567619-20-293   ·   File #:  1-32001

Previous ‘4’:  None   ·   Next:  ‘4’ on 2/3/20 for 1/31/20   ·   Latest:  ‘4’ on 2/7/24 for 2/5/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/03/20  Bejar Rafael                      4                      1:5K   Aptose Biosciences Inc.           Broadridge Fin’l… Inc/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      3K 
                Securities by an Insider -- doc1.xml/3.6


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0306 </schemaVersion>
<documentType> 4 </documentType>
<periodOfReport> 2020-01-01 </periodOfReport>
<notSubjectToSection16> 0 </notSubjectToSection16>
<issuer>
<issuerCik> 0000882361 </issuerCik>
<issuerName> Aptose Biosciences Inc. </issuerName>
<issuerTradingSymbol> APTO </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001797382 </rptOwnerCik>
<rptOwnerName> Bejar Rafael </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> C/O APTOSE BIOSCIENCES INC. </rptOwnerStreet1>
<rptOwnerStreet2> 251 CONSUMERS ROAD, SUITE 1105 </rptOwnerStreet2>
<rptOwnerCity> TORONTO </rptOwnerCity>
<rptOwnerState> A6 </rptOwnerState>
<rptOwnerZipCode> M2J 4R3 </rptOwnerZipCode>
<rptOwnerStateDescription> ONTARIO, CANADA </rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 0 </isDirector>
<isOfficer> 1 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
<officerTitle> Chief Medical Officer </officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable></nonDerivativeTable>
<derivativeTable>
<derivativeTransaction>
<securityTitle>
<value> Employee Stock Option (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 5.67 </value>
</conversionOrExercisePrice>
<transactionDate>
<value> 2020-01-01 </value>
</transactionDate>
<deemedExecutionDate></deemedExecutionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> A </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 400000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 0 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> A </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<exerciseDate>
<footnoteId id="F1"/>
</exerciseDate>
<expirationDate>
<value> 2030-12-31 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 400000 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 0 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeTransaction>
</derivativeTable>
<footnotes>
<footnote id="F1"> Fifty percent (50%) of the options vest on 1/1/2021; the remaining 50% vest as follows: 1/3 on 1/1/2022; 1/3 on 1/1/2023; and 1/3 on 1/1/2024. </footnote>
</footnotes>
<ownerSignature>
<signatureName> /s/ Janet Clennett as attorney-in-fact for Rafael Bejar </signatureName>
<signatureDate> 2020-01-03 </signatureDate>
</ownerSignature>
</ownershipDocument>


↑Top
Filing Submission 0001567619-20-000293   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 7:59:40.1am ET